Accelerate Diagnostics
Business Services · Arizona, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3950 S Country Club Rd Ste 470, Tucson, ...Phone Number
(520) 365-3100Revenue
$11.7 MillionStock Symbol
AXDXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Accelerate Diagnostics
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organismsExplore more
Accelerate Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accelerate Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Accelerate Diagnostics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Accelerate Diagnostics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Accelerate Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Accelerate Diagnostics recently announced quarterly report
Check if Accelerate Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Accelerate Diagnostics launches new products
Funding: Get notified immidiatlly once Accelerate Diagnostics has new funding data
Click to see if Accelerate Diagnostics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Accelerate Diagnostics
Find more new buyers
Compare Similar Companies to Accelerate Diagnostics
Compare insights from companies similar to Accelerate Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Accelerate Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Accelerate Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accelerate Diagnostics.
Accelerate Diagnostics financials insights
Gather financial insights about Accelerate Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
2024
Share Placement
$15M
Accelerate Diagnostics Tech Stack
A closer look at the technologies used by Accelerate Diagnostics
See more technologies
Most Recent Scoops
Project
Spending/Investment
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
Pain Point
Pain Point, Bankruptcy, Finance
Accelerate Diagnostics News & Media
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results
TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended December 31, 2024. 2024 Fourth Quarter Results Net sales for the quarter were $2.8 million, compared to $3.0 million for the same...Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today...Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
TUCSON, Ariz., Nov. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2024. "We are excited by the momentum we're building across our innovation pipeline, underscored by the successful launch of...Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
TUCSON, Ariz., Oct. 25, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced that management will host a conference call Thursday, November 7, 2024, at 4:30 p.m. Eastern Time to review 2024 third quarter results. To listen to the audio webcast online, visit...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accelerate Diagnostics
Sign Up For FreeTo access detailed company insights
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or... Read More
